"Expanding knowledge and access
to emergency contraception"
"Expanding knowledge and access to emergency contraception in Europe"
February 2026. A global review published in October 2025, highlights the important role sexual well-being plays in whether people continue using contraception. Drawing on data from 64 studies conducted between 2004 and 2023, the research found that around 5% of people who stopped using contraception—despite still wanting to prevent pregnancy —did so because of concerns…
February 2026 – A new qualitative study explored how community pharmacists in Australia make decisions about providing emergency contraception (EC) and how professional guidelines support this care. Pharmacists described existing guidelines as inaccessible, ambiguous, and impractical for use in busy pharmacy settings. The findings highlight the need for further research to optimise guideline usability and…
February 2026. The ASTRA Network and ECEC continue their collaboration to monitor access to emergency contraception across Central and Eastern Europe and Central Asia. In the latest issue of ASTRA’s Bulletin, we share findings on the discontinuation of low-dose mifepristone emergency contraceptive (EC) pills in the Russian Federation and the resulting impact on availability in…
February 2026. As of 1 February, levonorgestrel emergency contraceptive (EC) pills are available for sale in pharmacies and drugstores in Japan. Currently, only one brand of EC pills has been approved for non-prescription sale. The manufacturer’s suggested retail price is 7,480 yen: approximately USD 48 (Source: https://www.daiichisankyo-hc.co.jp.) According to ECEC data, prior to the regulatory…
January 2026. The European Consortium for Emergency Contraception (ECEC) reveals significant disparities in the availability and pricing of emergency contraceptive (EC) pills worldwide. The report Emergency contraceptive pills database – Data summary as of November 2025 is based on data from 127 countries, stored on the open-access database. Levonorgestrel (LNG) pills dominate the market, available…
January 2025. Two studies published in 2023 and 2025 provide the first empirical evidence on the impacts of introducing over-the-counter (OTC) emergency contraception (EC) in Europe. Both studies find that removing prescription requirements leads to substantial increases in EC use. A 2023 study by Gregor Pfeifer and Mirjam Stockburger (Journal of Health Economics) shows that…
Upcoming webinar hosted by the European Consortium for Emergency Contraception, featuring a conversation with Prof. Dr. Mirjam Stockburger, Data Economist at the Faculty of Economics and Business Studies of the Justus Liebig University Giessen. Wednesday, 4 February 3:00 PM – 3:45 PM CET (Barcelona, Berlin, Paris)Online event (registration required) The discussion will focus on findings…
January 2026. A new nationwide German study examined the pricing of emergency contraceptive (EC) pills in community pharmacies. Using a mystery caller methodology, 392 randomly selected pharmacies were asked about EC availability and prices. The study found substantial price variation, particularly for ulipristal acetate (UPA). Prices for UPA ranged from €17.00 to €43.71, while levonorgestrel…
January 2026 — In December 2025, European Union (EU) institutions reached a political agreement on a revised Victims’ Rights Directive confirming that survivors of sexual violence have the right to access sexual and reproductive healthcare, including emergency contraception, abortion care, and STI testing, where permitted under national law. This agreement marks the first time EU…
January 2026. According to the independent outlet Meduza, “since September 2025, Russia’s federal censorship agency, Roskomnadzor, has blocked websites accused of “promoting refusal of childbirth””, including pages that provided information on and access to emergency contraception (EC) pills. The Emergency Contraception Storage Fund, a grassroots initiative to secure access to EC pills, was forced to…
December 2025. ECEC and the International Planned Parenthood Federation (IPPF) have come together to merge their data on mifepristone for medical abortion and ulipristal acetate (UPA) for emergency contraception, with the aim of shedding light on the actual global availability of these essential medicines. A summary of this joint analysis has now been published in…
December 2025. A mystery-caller study from the Neubrandenburg University of Applied Sciences shows that more than half of German community pharmacies give advice on emergency contraception (EC) that does not align with national guidelines. In a scenario where EC was not medically indicated — a combined pill taken less than 12 hours late — only…
Menú